Search results
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Kestra Private Wealth Services LLC
ETF DAILY NEWS· 6 days agoKestra Private Wealth Services LLC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 5.6% in the 4th quarter, according ...
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
WJTV Jackson· 2 days agoBoston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately. Dr. Pegus has ...
The Zacks Analyst Blog Highlights Alphabet, Netflix, Amazon, ServiceNow and Boston Scientific
Zacks via Yahoo Finance· 3 days agoGOOGL, Netflix Inc. NFLX, Amazon.com Inc. AMZN, ServiceNow Inc. NOW and Boston Scientific Corp. BSX....
Citi Just Raised Its Price Target on These 3 Stocks
InvestorPlace via Yahoo Finance· 6 days agoMany Wall Street investors keep a close eye on the opinions of major brokerages, such as Citigroup (NYSE:C). Therefore, today we’ll explore three...
Inspire Medical Q1 Earnings Beat, Gross Margin Up - Boston Scientific (NYSE:BSX), Align Tech...
Benzinga· 21 hours agoInspire Medical Systems, Inc. INSP delivered a loss per share of 34 cents in first-quarter 2024,...
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
Zacks· 1 day agoFree Report) incurred an adjusted loss per share of 45 cents for first-quarter 2024, which was...
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
Zacks· 3 days agoStrong demand for Integra's (IART) diverse portfolio of leading brands and continued successful...
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
Zacks via Yahoo Finance· 17 hours agoSome better-ranked stocks in the broader medical space that have announced quarterly results are...
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
Zacks via Yahoo Finance· 17 hours agoSome better-ranked stocks in the broader medical space that have announced quarterly results are...
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
Zacks· 1 day agoOPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.